Advancing Education and Advocacy for the Small Cell Lung Cancer Community

Small Cell Lung Cancer (SCLC) accounts for approximately 15% of lung cancer diagnoses and has historically had a poor prognosis coupled with limited educational and support resources directly targeting this population. GO2 Foundation for Lung Cancer developed a SCLC Initiative to reach, build, and learn from the SCLC community - an underserved patient group that has proven challenging to identify and engage in an on-going, consistent way. The goals were to increase SCLC awareness and education in patients and caregivers, improve small cell clinical trial knowledge and accrual, and to begin to build a connected SCLC community.